These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32481364)

  • 1. Study on efficacy and safety of Huangqi Guizhi Wuwu decoction treatment for oxaliplatin induced peripheral neurotoxicity: A protocol for a randomized, controlled, double-blind, multicenter trial.
    Wei XM; Chen XF; Shu P; Jiang ZW; Wu XY; Zou X; Chen K; Shen B; Hu WW; Lu W; Shen WX; Li L; Wang JY; Zhao FJ; Yin QF; Cheng HB; Gu YH
    Medicine (Baltimore); 2020 May; 99(22):e19923. PubMed ID: 32481364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Huangqi Guizhi Wuwu Decoction for Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review and Meta-Analysis.
    Yu J; Chen S; Wei G; Gu J; Huo J; Ding R; Li L
    Altern Ther Health Med; 2024 Jan; 30(1):446-453. PubMed ID: 37820675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
    Gu Z; Wei G; Zhu L; Zhu L; Hu J; Li Q; Cai G; Lu H; Liu M; Chen C; Ji Y; Li G; Huo J
    Evid Based Complement Alternat Med; 2021; 2021():5551568. PubMed ID: 34630609
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy and safety of Huangqi Guizhi Wuwu decoction for rheumatoid arthritis: A protocol for systematic review and meta-analysis.
    Wang L; Fan Y; Xin P; Zhao Y; Deng H; Jia B
    Medicine (Baltimore); 2020 Sep; 99(36):e22011. PubMed ID: 32899051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study of Jiawei Huangqi Guizhi Wuwu Decoction in preventing and treating peripheral neuro-sensory toxicity caused by oxaliplatin.
    Li Y; Cui HJ; Huang JC; Wu XQ
    Chin J Integr Med; 2006 Mar; 12(1):19-23. PubMed ID: 16571278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huangqi Guizhi Wuwu Decoction can prevent and treat oxaliplatin-induced neuropathic pain by TNFα/IL-1β/IL-6/MAPK/NF-kB pathway.
    Li M; Li Z; Ma X; Jin S; Cao Y; Wang X; Zhao J; Wang J; Wang X; Xu J
    Aging (Albany NY); 2022 Jun; 14(12):5013-5022. PubMed ID: 35759577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huangqi Guizhi Wuwu decoction in peripheral neurotoxicity treatment using network pharmacology and molecular docking.
    Chen T; Shi Y; Shi W
    Medicine (Baltimore); 2022 Oct; 101(42):e31281. PubMed ID: 36281162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huangqi Guizhi Wuwu decoction alleviates oxaliplatin-induced peripheral neuropathy via the gut-peripheral nerve axis.
    Zhang Z; Ye J; Liu X; Zhao W; Zhao B; Gao X; Lan H; Wu Y; Yang Y; Cao P
    Chin Med; 2023 Sep; 18(1):114. PubMed ID: 37679804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research progress on Huangqi Guizhi Wuwu Decoction and predictive analysis of quality markers].
    Lu GY; Wang JY; Gao Z; Ma K; Yu HY; Wang SJ
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5438-5449. PubMed ID: 38114137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-seq revealed the protective effect of Huangqi Guizhi Wuwu Decoction against cisplatin induced PC12 cell injury.
    Cheng J; Dong Y; Wu J; Shao C; Tang YC; Dong ZQ
    Int J Neurosci; 2024 Aug; ():1-11. PubMed ID: 39155776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective, Randomized, Placebo-Controlled Study Assessing the Efficacy of Chinese Herbal Medicine (Huangqi Guizhi Wuwu Decoction) in the Treatment of Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy.
    Chai Y; Zhao F; Ye P; Ma F; Wang J; Zhang P; Li Q; Wang J; Wang W; Li Q; Xu B
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [UPLC-Q-TOF-MS analysis on chemical constituents of classical prescription Huangqi Guizhi Wuwu Tang standard decoction].
    Xu RL; Fan JT; Dong HM; Chen XQ; Xu JD; Huo JG; Ju JM
    Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5614-5630. PubMed ID: 33496099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
    Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
    BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial.
    Kerckhove N; Tougeron D; Lepage C; Pezet D; Le Malicot K; Pelkowski M; Pereira B; Balayssac D
    BMC Cancer; 2022 Jul; 22(1):742. PubMed ID: 35799138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer.
    Wang DS; Wang ZQ; Chen G; Peng JW; Wang W; Deng YH; Wang FH; Zhang JW; Liang HL; Feng F; Xie CB; Ren C; Jin Y; Shi SM; Fan WH; Lu ZH; Ding PR; Wang F; Xu RH; Li YH
    Cancer Med; 2020 Jan; 9(1):151-159. PubMed ID: 31724334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observation of the curative effect of Guizhi-Shaoyao-Zhimu decoction combined with methotrexate in the treatment of early rheumatoid arthritis based on ultrasonic evaluation: study protocol of a randomized, double-blind, controlled clinical trial.
    Shen J; Chen Q; Yang G; He Y
    Trials; 2021 Nov; 22(1):764. PubMed ID: 34732237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huangqi Guizhi Wuwu Decoction for treating diabetic peripheral neuropathy: a meta-analysis of 16 randomized controlled trials.
    Pang B; Zhao TY; Zhao LH; Wan F; Ye R; Zhou Q; Tian F; Tong XL
    Neural Regen Res; 2016 Aug; 11(8):1347-58. PubMed ID: 27651785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the Efficacy and Safety of the Huangqi Guizhi Wuwu Decoction in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Meta-Analysis of 32 Randomized Controlled Trials.
    Yang XR; Zhang XY; Xia YJ; Fu J; Lian XX; Liang XR; He YQ; Li ZH
    J Pain Res; 2024; 17():2605-2628. PubMed ID: 39139997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the mechanism of Huangqi Guizhi Wuwu Decoction in treating diabetes peripheral neuropathy based on network pharmacology and molecular docking.
    Ai B; Zhang W; Li G
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):119-126. PubMed ID: 38814227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huangqi Guizhi Wuwu decoction for diabetic peripheral neuropathy: Protocol for a systematic review.
    Zhang Y; Gong G; Zhang X; Zhou L; Xie H; Tian Y; Xie C
    Medicine (Baltimore); 2019 Aug; 98(31):e16696. PubMed ID: 31374060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.